Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
8,959 total articles
Lumentum Holdings shares jumped after NVIDIA announced a $2 billion investment tied to a multiyear strategic agreement centered on advanced optics for AI infrastructure. The nonexclusive arrangement includes a multibillion-dollar purchase commitment from NVIDIA and rights to future capacity for advanced laser components, while the funding is earmar…
U.S. equities closed lower on Friday after producer prices came in well above forecasts, intensifying already-elevated market volatility. Major indexes finished the month in the red as investors wrestle with questions about inflation persistence, the economic implications of artificial intelligence developments, and a sharp escalation of conflict i…
Nvidia, hyperscalers, chipmakers and investors have announced a wide array of multi-billion-dollar arrangements to expand artificial intelligence compute, storage and model capabilities. The deals span direct chip and cloud purchases, equity investments, long-term contracts for data center capacity, and licensing agreements for content and model us…
KeyBanc Capital Markets analysts reiterated a bullish view on U.S. oil producers after a sharp escalation of conflict in the Middle East. The firm argues that current equity valuations do not fully reflect a tightening supply outlook, and singled out seven companies - Crescent Energy, Diamondback Energy, Magnolia Oil & Gas, Matador Resources, SM En…
JPMorgan has restarted coverage of Netflix with an Overweight rating and a $120 price target after the streaming company withdrew from a costly acquisition pursuit of Warner Bros. The broker highlights Netflix's organic growth, pricing power, still-under-monetized ad tier and forecasted margin expansion, while markets have rewarded the stock follow…
Etihad Airways has resumed a small number of operations from Abu Dhabi amid widespread Middle East airspace closures triggered by recent military actions. The carrier said select repositioning, cargo and repatriation services may run with UAE authority approvals, while all scheduled commercial services in and out of Abu Dhabi remain cancelled. The …
UBS strategist Bhanu Baweja warns that the recent escalation involving Iran is unfolding faster and more broadly than markets expected. The firm highlights the duration of any shipping disruption in the Strait of Hormuz as the central variable: even partial impairment lasting several weeks could sharply unsettle oil and global markets. Elevated equ…
Thomson Reuters has appointed Gary E. Bischoping Jr., a former Dell executive and recent private equity partner, as its next chief financial officer effective May 8. He will join the company on April 13 and will participate in the firm's first-quarter earnings call on May 5 alongside current CFO Mike Eastwood, who will step down and transition to c…
Citi has raised its recommendation on U.K. equities from Underweight to Overweight, arguing that the market’s sector composition - with a heavy presence of Commodities, Defensive sectors and a meaningful weighting in Aerospace & Defense - offers a hedge against geopolitical uncertainty tied to recent developments in Iran. The bank also flagged a hi…
Analysts at BofA Securities say recent U.S. and Israeli strikes on Iran carry serious geopolitical consequences but are unlikely to produce a prolonged conflict. The team sees limited upside pressure on oil prices - roughly $10 to $15 a barrel - while cautioning that tail risks have increased and could pose stagflationary dangers if prices spike an…
Coherent Corp. shares jumped after Nvidia disclosed a $2 billion investment as part of a multiyear strategic agreement to advance optical and laser technologies for AI data centers. The nonexclusive deal includes a multibillion-dollar purchase commitment from Nvidia along with access and capacity rights to advanced laser and optical networking prod…
Intellia Therapeutics shares climbed in premarket trading after the U.S. Food and Drug Administration lifted a clinical hold on a late-stage trial of nexiguran ziclumeran, an experimental gene-editing therapy for transthyretin amyloid cardiomyopathy (ATTR-CM). The FDA had previously paused two principal late-stage studies following a patient death …
Macquarie says South Korean stocks remain attractively priced after a roughly 160% rally since 2024, arguing that the advance is grounded in strong earnings revisions, abundant liquidity and supportive government measures. The bank highlights memory chipmakers as the primary engine of profit growth while also favoring exporters in defence, shipbuil…
Evercore ISI maintains that recent volatility in the S&P 500 does not negate a broader upward trend, raising its 2026 earnings-per-share forecast and identifying the 6,520 level as likely support during any retracement. The firm recommends adding exposure on weakness, particularly to AI-related names, and points to tech, materials and industrials a…
RBC Capital Markets has identified two retail companies it views as best positioned for 2026, recommending investors focus on defensive, high-margin names. The broker highlights balance sheet strength, pricing power and operational agility as key differentiators. It reiterates an outperform rating on Inditex, citing its vertically integrated supply…
Growing U.S.-Israeli military action against Iran has injected fresh uncertainty into a Middle East that has been drawing major technology capital. Global cloud providers and chip partners have committed billions to AI, semiconductor and data-center projects across the Gulf, with major planned investments by Microsoft, Amazon Web Services, Alphabet…
U.S. stock futures fell and commodity prices rose after renewed hostilities involving Iran, the U.S. and Israel. Market participants focused on potential disruptions to oil flows through the Strait of Hormuz and on heightened safe-haven demand for gold. Wall Street analysts offered a range of assessments about the conflict's likely duration, potent…
Analysts at Barclays argue European insurers may provide a defensive stance within financial stocks as the U.S.-Iran conflict intensifies. They point to limited underwriting exposure to war-related losses, concentrated specialty lines primarily at London Market insurers and reinsurers, and historically high levels of reinsurance. A stronger U.S. do…
U.S. stock futures opened lower as a widening conflict in the Middle East prompted traders to abandon risk assets. Energy and defense equities rallied on higher crude and military-related demand, while leisure, airlines and select tech names fell amid operational disruptions and earnings pressures. A number of individual companies recorded notable …
Saudi Arabia's stock market closed slightly higher on Monday, supported by gains in the Energy & Utilities, Petrochemicals and Industrial Investment sectors. The Tadawul All Share rose 0.13% as a handful of names produced notable advances while several others fell to all-time lows. Oil and gold prices climbed sharply during the session, and cur…
Shares of leading U.S. defense contractors rose sharply on Monday following a large-scale joint military operation by Israel and the United States against Iran. The offensive, named "Operation Epic Fury," has reportedly killed senior figures including Iranian Supreme Leader Ayatollah Ali Khamenei and is expected to continue for days. Analysts say t…
Zoetis Inc. announced an agreement to acquire Neogen Corporation's animal genomics business for $160 million, a move that grants Zoetis access to genetic testing technologies and data tools intended to enhance animal health predictions and individualized care. The deal, which covers a genomics unit operating five laboratories across multiple contin…
Informa PLC shares fell 6.04% on Monday after recent geopolitical developments in the Middle East raised concerns about the company’s reliance on the region for fast-growing live B2B events revenue. Morgan Stanley estimates significant revenue concentration in IMEA for 2025 and outlines potential group-level impacts to revenue and adjusted profits …
Goldman Sachs lowered its rating on Danish drugmaker Novo Nordisk to neutral from buy and reduced its 12-month price objective to DKK260 from DKK400 after the REDEFINE-4 results prompted a material downgrade in peak sales expectations for CagriSema and cagrilintide monotherapy. The bank also adjusted group revenue, profit and EPS forecasts downward…
JPMorgan analyst Mislav Matejka argues that the recent escalation tied to Iran should be treated as a buying opportunity for longer-term investors rather than a reason to exit markets. While acknowledging likely short-term risk-off behavior and volatility, Matejka points to positive underlying fundamentals - resilient activity momentum, a consumer …
